The functional human genomics laboratory studies the genetic basis of human diseases with special reference to chronic degenerative diseases with high impact in rehabilitation such as neurodegenerative and cardiovascular diseases. Researchers are working to identify new disease-genes and molecular pathways to improve the care and personalize rehabilitation and treatment of people with diseases with a high genetic component. Mendelian and genomic diseases as well as predominantly neurodegenerative diseases caused by polynucleotide expansion in noncoding sequences of the genome are the subject of research. The aim is to identify new molecular markers that will allow defining individual susceptibility and different response to pharmacological, therapeutic, and nutritional treatments. These markers are the tool for developing individualized diagnostic-therapeutic and rehabilitation protocols for predictive and personalized medicine.